BMJ 2000;321:78-82 ( 8 July )

Papers

Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey

Shane Allwright, senior lecturer in epidemiology, ^a Fiona Bradley, lecturer in general practice, ^a Jean Long, lecturer in international health and development, ^a Joseph Barry, senior lecturer in public health, ^a Lelia Thornton, specialist in public health medicine, ^b John V Parry, deputy director. ^c

^a Department of Community Health and General Practice, Trinity College, Dublin 2, Republic of Ireland, ^b Department of Public Health, Eastern Regional Health Authority, Dr Steevens' Hospital, Dublin 8, Republic of Ireland, ^c Hepatitis and Retrovirus Laboratory, PHLS Central Public Health Laboratory, London NW9 5HT

Correspondence to: S Allwright sllwrght{at}tcd.ie

Objectives: To determine the prevalence of antibodies to hepatitis B core antigen, hepatitis C virus, and HIV in the prison population of the Republic of Ireland and to examine risk factors for infection.
Design: Cross sectional, anonymous, unlinked survey, with self completed risk factor questionnaire and provision of oral fluid specimen for antibody testing.
Setting: Nine of the 15 prisons in the Republic of Ireland.
Participants: 1366 prisoners, of whom 1205 (57 women) participated. In the smaller prisons all prisoners were surveyed, while in the three largest prisons one half of the population was randomly sampled. Three small prisons believed not to have a problem with injecting drug use were excluded.
Main outcome measures: Prevalence of antibodies to hepatitis B core antigen, antibodies to hepatitis C virus, and antibodies to HIV. Self reported risk factor status.
Results: Prevalence of antibodies to hepatitis B core antigen was 104/1193 (8.7%; 95% confidence interval 7.2% to 10.5%), to hepatitis C virus, 442/1193 (37%; 34.3% to 39.9%), and to HIV, 24/1193 (2%; 1.3% to 3%). The most important predictor of being positive for hepatitis B and hepatitis C was a history of injecting drug use. Thirty four women (60%) and 474 men (42%) reported ever injecting drugs. A fifth (104) of 501 injecting drug users reported first injecting in prison, and 347 (71%) users reported sharing needles in prison.
Conclusions: Infection with hepatitis C secondary to use of injected drugs is endemic in Irish prisons. Better access to harm reduction strategies is needed in this environment.

---

© BMJ 2000
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Health effects of prisons

Bobby P Smyth, Herbert Langkamp, Matthias L Schmid, Stephen T Green, Michael W McKendrick, and Noel McCarthy
BMJ 2000 321: 1406. [Extract] [Full Text]

Drug use and hepatitis are endemic in Irish prisons
BMJ 2000 321: 0. [Full Text]

This article has been cited by other articles:

• Epperson, M. W., Platais, I., Valera, P., Barbieri, R., Gilbert, L., El-Bassel, N. (2009). Fear, Trust, and Negotiating Safety: HIV Risks for Black Female Defendants. Affilia 24: 257-271 [Abstract]  
• Chong, V. H. (2008). Screening blood-borne virus among incarcerated inmates. Int J STD AIDS 19: 795-795 [Full text]  
• Vescio, M F, Longo, B, Babudieri, S, Starnini, G, Carbonara, S, Rezza, G, Monarca, R (2008). Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J. Epidemiol. Community Health 62: 305-313 [Abstract] [Full text]  
• Poulin, C. MSc, Alary, M. MD PhD, Lambert, G. MD, Godin, G. PhD, Landry, S. MA, Gagnon, H. MA, Demers, E. MSc, Morarescu, E. MD MSc, Rochefort, J. MSc, Claessens, C. MSc (2007). Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. CMAJ 177: 252-256 [Abstract] [Full text]  
• Comiskey, C., Saris, J., Pugh, J. (2007). Estimating the prevalence of opiate use in Ireland and the implications for the criminal justice system. Probation Journal 54: 22-35 [Abstract]  
• Senok, A. C., Botta, G. A. (2006). Human immunodeficiency virus and hepatitis virus infection in correctional institutions in Africa: is this the neglected source of an epidemic?. J Med Microbiol 55: 481-482 [Full text]  
• Perez, C. M, Suarez, E., Torres, E. A, Roman, K., Colon, V. (2005). Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico. Int J Epidemiol 34: 593-599 [Abstract] [Full text]  
• Smyth, B. P, Barry, J., Keenan, E. (2005). Irish injecting drug users and hepatitis C: the importance of the social context of injecting. Int J Epidemiol 34: 166-172 [Abstract] [Full text]  
• Montella, M, Crispo, A, Wynn-Bellezza, J (2004). In search of the correct strategy for preventing the spread of HCV infection. Gut 53: 771-772 [Full text]  
• Skipper, C, Guy, J M, Parkes, J, Roderick, P, Rosenberg, W M (2003). Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy. Gut 52: 1500-1504 [Abstract] [Full text]  
• Duffy, D., Lenihan, S., Kennedy, H. G. (2003). Screening prisoners for mental disorders. Psychiatr. Bull. 27: 241-242 [Full text]  
• Buavirat, A., Page-Shafer, K., van Griensven, G J P, Mandel, J S, Evans, J, Chuaratanaphong, J, Chiamwongpat, S, Sacks, R, Moss, A (2003). Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ 326: 308-308 [Abstract] [Full text]  
• Barry, J (2002). Policy response to opioid misuse in Dublin. J. Epidemiol. Community Health 56: 6-7 [Full text]  
• Long, J., Allwright, S., Barry, J., Reynolds, S. R., Thornton, L., Bradley, F., Parry, J. V, Bird, S. M (2001). Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey Commentary: efficient research gives direction on prisoners' and the wider public health---except in England and Wales. BMJ 323: 1209-1209 [Abstract] [Full text]  
• Laniado-Laborin, R. (2001). Tuberculosis in Correctional Facilities : A Nightmare Without End in Sight. Chest 119: 681-683 [Full text]  
• Smyth, B. P, Langkamp, H., Schmid, M. L, Green, S. T, McKendrick, M. W, McCarthy, N. (2000). Health effects of prisons. BMJ 321: 1406a-1406 [Full text]  

Rapid Responses:

Read all Rapid Responses

We need evidence of the risks and benefits of introducing needle exchange schemes in prison

Bobby P Smyth
bmj.com, 20 Jul 2000 [Full text]

The criminal justice system, health inequalities, the medical profession and the BMJ..

Noel McCarthy
bmj.com, 28 Jul 2000 [Full text]

The BMJ and the health aspects of imprisonment

Richard Smith
bmj.com, 29 Jul 2000 [Full text]

OF THE IMPORTANCE OF GENOTYPING HCV

Malik T Qayyum
bmj.com, 4 Aug 2000 [Full text]

Low levels of hepatitis B vaccination uptake in hepatitis C positive prisoners

Matthias L Schmid
bmj.com, 8 Aug 2000 [Full text]

The risks of syringe exchange program in prisons prevail

Herbert Langkamp
bmj.com, 17 Aug 2000 [Full text]

Online poll

Find out more on doc2doc >>